Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 7

1.

Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.

Donohue JM, Fischer MA, Huskamp HA, Weissman JS.

Health Serv Res. 2008 Oct;43(5 Pt 1):1557-75. doi: 10.1111/j.1475-6773.2008.00858.x. Epub 2008 May 13.

2.

[Secondary prevention after cardiac infarct; therapeutic efficiency--cost-benefit ratio].

Kreuzer J, K├╝bler W.

Internist (Berl). 2001 May;42(5):713-9. Review. German. No abstract available.

PMID:
11400578
3.

Capillary electrophoresis of cardiovascular drugs.

Nguyen NT, Siegler RW.

J Chromatogr A. 1996 May 31;735(1-2):123-50. Review.

PMID:
8767740
4.

Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers.

Davis EM, Packard KA, Hilleman DE.

Pharmacotherapy. 2010 Jul;30(7):749, 274e-318e. doi: 10.1592/phco.30.7.749. Review.

PMID:
20575638
6.

[Changes in the prescription of cardiovascular prevention drugs in France between 1995 and 2003: factors influencing the gap between evidence base medicine and clinical practice].

Philippe F, Cambou JP, Danchin N, Thomas D.

Ann Cardiol Angeiol (Paris). 2005 Dec;54 Suppl 1:S30-6. Review. French.

PMID:
16411649
7.

The cost-effectiveness of direct-to-consumer advertising for prescription drugs.

Atherly A, Rubin PH.

Med Care Res Rev. 2009 Dec;66(6):639-57. doi: 10.1177/1077558709335362. Epub 2009 May 7. Review.

PMID:
19423875
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk